GenomIdea Inc., 1-8-31, Midorigaoka, Ikeda, Osaka 563-0026, Japan.
Curr Top Med Chem. 2012;12(15):1594-602. doi: 10.2174/156802612803531487.
Drug delivery systems for gene transfer are called 'vectors'. These systems were originally invented as a delivery system for the transfection in vitro or in vivo. Several vectors are then developed for clinical use of gene medicines and currently some of them are approved as animal drugs. Conventional drug delivery system generally consists of approved (existing) materials to avoid additional pre-clinical or clinical studies. However, current vectors contain novel materials to improve an efficacy of gene medicines. Thus, these vectors have functions more than a mere delivery of active ingredients. For example some vectors have immunological functions such as adjuvants in vaccines. These new types of vectors are called 'intelligent' or 'innovative' vector system', since the concept or strategy for the development is completely different from conventional drug delivery systems. In this article, we described a current status of 'intelligent gene transfer vectors and discussed on the potentials of them.
用于基因转移的药物输送系统被称为“载体”。这些系统最初是作为体外或体内转染的输送系统而发明的。随后开发了几种载体用于基因药物的临床应用,目前其中一些已被批准为动物药物。传统的药物输送系统通常由已批准(现有)的材料组成,以避免额外的临床前或临床研究。然而,目前的载体包含新的材料,以提高基因药物的疗效。因此,这些载体具有比仅仅输送有效成分更多的功能。例如,一些载体具有免疫功能,如疫苗中的佐剂。这些新型载体被称为“智能”或“创新”载体系统,因为其开发的概念或策略与传统药物输送系统完全不同。在本文中,我们描述了“智能基因转移载体”的现状,并讨论了它们的潜力。